Nano-metal-organic-frameworks for treating H<sub>2</sub>O<sub>2</sub>-Secreting bacteria alleviate pulmonary injury and prevent systemic sepsis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34749071.
- Also identified by DOI 10.1016/j.biomaterials.2021.121237.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As a vital bacteria-secreted toxin, hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) can destroy infected tissues and increase vascular permeability, leading to life-threatening systemic bacteremia or sepsis. No strategy that can alleviate H<sub>2</sub>O<sub>2</sub>-induced injury and prevent systemic sepsis has been reported. Herein, as a proof of concept, we demonstrate the use of H<sub>2</sub>O<sub>2</sub>-reactive metal-organic framework nanosystems (MOFs) for treating H<sub>2</sub>O<sub>2</sub>-secreting bacteria. In mice infected with Streptococcus pneumoniae (S. pneumoniae) isolated from patients, MOFs efficiently accumulate in the lungs after systemic administration due to infection-induced alveolar-capillary barrier dysfunction. Moreover, MOFs sequester pneumococcal H<sub>2</sub>O<sub>2</sub>, reduce endothelial DNA damage, and prevent systemic dissemination of bacteria. In addition, this nanosystem exhibits excellent chemodynamic bactericidal effects against drug-resistant bacteria. Through synergistic therapy with the antibiotic ampicillin, MOFs eliminate over 98% of invading S. pneumoniae, resulting in a survival rate of greater than 90% in mice infected with a lethal dose of S. pneumoniae. This work opens up new paths for the clinical treatment of toxin-secreting bacteria.
Medical subject headings
- Lung Injury
- Metal-Organic Frameworks
- Sepsis